{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:38:12Z","timestamp":1782902292483,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T00:00:00Z","timestamp":1473897600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"IBSA Institut Biochimique SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40261-016-0451-6","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T09:36:40Z","timestamp":1473932200000},"page":"1031-1044","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin"],"prefix":"10.1007","volume":"36","author":[{"given":"Andrea F. D.","family":"Di Stefano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rusca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milko M.","family":"Radicioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Loprete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Binelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Caccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Cometti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"key":"451_CR1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.humrep.a138147","volume":"8","author":"MM Wiessenbruch Van","year":"1993","unstructured":"Van Wiessenbruch MM, Schoemaker HC, Drexhage HA, Schoemaker J. Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration initiating follicular growth in polycystic ovary-like disease. Hum Reprod. 1993;8:813\u201321.","journal-title":"Hum Reprod"},{"key":"451_CR2","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/oxfordjournals.humrep.a138761","volume":"9","author":"M Meer van der","year":"1994","unstructured":"van der Meer M, Hompes PGA, Scheele F, Schoute E, Veersema S, Schoemaker J. Follicle stimulating hormone (FSH) dynamics of low dose set-up ovulation induction with FSH in patients with polycystic ovary syndrome. Hum Reprod. 1994;9:1612\u20137.","journal-title":"Hum Reprod"},{"issue":"1","key":"451_CR3","first-page":"71","volume":"18","author":"BCJM Fauser","year":"1997","unstructured":"Fauser BCJM, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev. 1997;18(1):71\u2013106.","journal-title":"Endocr Rev."},{"key":"451_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0015-0282(16)57652-3","volume":"64","author":"EJP Santbrink van","year":"1995","unstructured":"van Santbrink EJP, van Dessel HJHM, Hop WC, De Jong FH, Fauser BCJM. Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril. 1995;64:37\u201343.","journal-title":"Fertil Steril"},{"key":"451_CR5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3346\/jkms.2008.23.1.104","volume":"23","author":"SY Shin","year":"2008","unstructured":"Shin SY, Lee JR, Noh GW, Kim HJ, Kang WJ, Kim SH, et al. Analysis of serum levels of anti-M\u00fcllerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein-3 and follicle-stimulating hormone with respect to age and menopausal status. J Korean Med Sci. 2008;23:104\u201310.","journal-title":"J Korean Med Sci."},{"issue":"2","key":"451_CR6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.gme.0000198489.49618.96","volume":"13","author":"JB Henrich","year":"2006","unstructured":"Henrich JB, Hughes JP, Kaufman SC, Brody DJ, Curtin LR. Limitations of follicle-stimulating hormone in assessing menopause status: findings from the National Health and Nutrition Examination Survey (NHANES 1999\u20132000). Menopause. 2006;13(2):171\u20137.","journal-title":"Menopause."},{"issue":"12","key":"451_CR7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jcem-18-12-1333","volume":"18","author":"CA Gemzell","year":"1958","unstructured":"Gemzell CA, Diczfalusy E, Tillinger G. Clinical effect of human pituitary follicle-stimulating hormone (FSH). J Clin Endocrinol Metab. 1958;18(12):1333\u201348.","journal-title":"J Clin Endocrinol Metab."},{"key":"451_CR8","first-page":"346","volume":"35","author":"B Lunenfeld","year":"1962","unstructured":"Lunenfeld B, Sulimovici S, Rabau E, Eshkol A. L\u2019induction de l\u2019ovulation dans les amenorrhees hypophysaires par un traitement combine de gonadotrophines urinaires menopausiques et de gonadotropins chronique. CR Soc Franc Gynecol. 1962;35:346\u201356.","journal-title":"CR Soc Franc Gynecol."},{"key":"451_CR9","unstructured":"Lunenfeld B, Sulimovici S, Rabau E. Urinary gonadotropins in treatment of pituitary amenorrhea. Proc Tel-Hashomer Hosp. 1962;1:25."},{"key":"451_CR10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3181\/00379727-71-17144","volume":"71","author":"JT Breadbury","year":"1949","unstructured":"Breadbury JT, Brown ES, Brown WE. Adsorption of urinary gonadotrophins on kaolin. Proc Soc Exp Biol Med. 1949;71:228\u201332.","journal-title":"Proc Soc Exp Biol Med"},{"key":"451_CR11","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/oxfordjournals.humrep.a138440","volume":"9","author":"E Giudice","year":"1994","unstructured":"Giudice E, Crisci C, Eshkol A, Papoian R. Composition of commercial gonadotrophin preparations extracted from human post-menopausal urine: characterization of non-gonadotrophin proteins. Hum Reprod. 1994;9:2291\u20139.","journal-title":"Hum Reprod"},{"key":"451_CR12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1472-6483(10)62071-8","volume":"7","author":"BH Weijer Van den","year":"2003","unstructured":"Van den Weijer BH, Mulders JW, Bos ES, Verhaert PD, Van den Hooven HW. Compositional analyses of a human menopausal gonadotrophin preparation extracted from urine (menotrophin). Identification of some of its major impurities. Reprod Biomed Online. 2003;7:547\u201357.","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"451_CR13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0015-0282(02)04202-4","volume":"78","author":"HA Selman","year":"2002","unstructured":"Selman HA, De Santo M, Sterzik K, Coccia E, El-Danasouri I. Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality. Fertil Steril. 2002;78(5):1061\u20137.","journal-title":"Fertil Steril."},{"key":"451_CR14","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/oxfordjournals.humrep.a019506","volume":"11","author":"R Fleming","year":"1996","unstructured":"Fleming R, Chung CC, Yates RW, Coutts JR. Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity. Hum Reprod. 1996;11:1854\u20138.","journal-title":"Hum Reprod"},{"issue":"5","key":"451_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1477-7827-5-45","volume":"4","author":"C Alviggi","year":"2007","unstructured":"Alviggi C, Revelli A, Anserini P, Ranieri A, Fedele L, Strina I, et al. A prospective, randomised, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing multifollicular ovarian stimulation in an ART programme (IVF). Reprod Biol Endocrinol. 2007;4(5):45.","journal-title":"Reprod Biol Endocrinol."},{"issue":"2","key":"451_CR16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0015-0282(16)54493-8","volume":"56","author":"W Saal","year":"1991","unstructured":"Saal W, Happ J, Cordes U, Baum RP, Schmidt M. Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hypogonadism. Fertil Steril. 1991;56(2):319\u201324.","journal-title":"Fertil Steril."},{"issue":"5","key":"451_CR17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/01443619609030060","volume":"16","author":"APE Schmoutziguer","year":"1996","unstructured":"Schmoutziguer APE, Van Kooij RJ, Te Velde ER, Geurts TBP, de Leeuw R, Rombout F. Retrospective analysis of subcutaneous administration of urinary gonadotrophins in in vitro fertilisation. J Obstet Gynaecol. 1996;16(5):409\u201313.","journal-title":"J Obstet Gynaecol"},{"issue":"Suppl 5","key":"451_CR18","first-page":"S13","volume":"90","author":"The Practice Committee of the American Society for Reproductive Medicine, Birmingham, Alabama","year":"2008","unstructured":"The Practice Committee of the American Society for Reproductive Medicine, Birmingham, Alabama. Gonadotropin preparations: past, present, and future perspectives. Fertil Steril. 2008;90(Suppl 5):S13\u201320.","journal-title":"Fertil Steril"},{"key":"451_CR19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/humrep\/deg088","volume":"18","author":"HG Al-Inany","year":"2003","unstructured":"Al-Inany HG, Abou-Setta AM, Aboulghar MA, Mansour RT, Serour GI. HMG versus rFSH for ovulation induction in developing countries: a cost-effectiveness analysis based on the results of a recent meta-analysis. Hum Reprod. 2003;18:305\u201313.","journal-title":"Hum Reprod"},{"key":"451_CR20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/09513590400027232","volume":"20","author":"H Al-Inany","year":"2005","unstructured":"Al-Inany H, Aboulghar MA, Mansour RT, Serour GI. Ovulation induction in the new millennium: recombinant follicle-stimulating hormone versus human menopausal gonadotropin. Gynecol Endocrinol. 2005;20:161\u20139.","journal-title":"Gynecol Endocrinol"},{"key":"451_CR21","first-page":"CD003973","volume":"1","author":"M Wely Van","year":"2003","unstructured":"Van Wely M, Westergaard LG, Bossuyt PM, Van der Veen F. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2003;1:CD003973.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"451_CR22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/09513590.2011.569612","volume":"28","author":"HG Al-Inany","year":"2012","unstructured":"Al-Inany HG, Abou-Setta AM. Are all human-derived FSH products the same? A systematic review and meta-analysis using direct and adjusted indirect analyses to determine if Fostimon\u00ae is more efficient than Metrodin-HP\u00ae. Gynecol Endocrinol. 2012;28(2):94\u2013101.","journal-title":"Gynecol Endocrinol."},{"key":"451_CR23","first-page":"CD005354","volume":"2","author":"M Wely Van","year":"2011","unstructured":"Van Wely M, Kwan I, Burt AL, Thomas J, Vail A, Van der Veen F, et al. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database Syst Rev. 2011;2:CD005354.","journal-title":"Cochrane Database Syst Rev"},{"key":"451_CR24","unstructured":"National Institute for Health and Care Excellence (NICE). Fertility: assessment and treatment for people with fertility problems. NICE guideline CG156. London: NICE; 2013."},{"issue":"10","key":"451_CR25","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/oxfordjournals.humrep.a137899","volume":"8","author":"JY Cotonnec le","year":"1993","unstructured":"le Cotonnec JY, Porchet HC, Beltrami V, Howles C. Comparative pharmacokinetics of two urinary huma follicle stimulating hormone preparations in healthy female and male volunteers. Hum Reprod. 1993;8(10):1604\u201311.","journal-title":"Hum Reprod"},{"key":"451_CR26","first-page":"125","volume-title":"Ovulation induction: basic science and clinical advances","author":"C Flamigni","year":"1994","unstructured":"Flamigni C, Venturoli S, Dal Parto L, Porcu E. Purified FSH: characteristics and applications. In: Follicori M, Flamigni C, editors. Ovulation induction: basic science and clinical advances. Amsterdam: Elsevier Science; 1994. p. 125\u201334."},{"issue":"6","key":"451_CR27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/humupd\/dmh044","volume":"10","author":"B Lunenfeld","year":"2004","unstructured":"Lunenfeld B. Historical perspectives in gonadotrophin therapy. Hum Reprod Update. 2004;10(6):453\u201367.","journal-title":"Hum Reprod Update"},{"key":"451_CR28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/oxfordjournals.humrep.a019035","volume":"11","author":"HJ Out","year":"1996","unstructured":"Out HJ, Schnabel PG, Rombout F, Geurts TBP, Bosschaert MAR, Coelingh Bennink HJT. A bioequivalence study of two urinary follicle stimulating hormone preparations: Follegon and Metrodin. Hum Reprod. 1996;11:61\u20133.","journal-title":"Hum Reprod"},{"key":"451_CR29","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/humrep\/14.7.1698","volume":"14","author":"G Voortman","year":"1999","unstructured":"Voortman G, van de Post J, Schoemaker RC, van Gerven JMA. Bioequivalence of subcutaneous injection of recombinant human FSH (Puregon\u00ae) by Pen-injector and syringe. Hum Reprod. 1999;14:1698\u2013702.","journal-title":"Hum Reprod"},{"key":"451_CR30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/humrep\/12.1.34","volume":"12","author":"JA Huisman","year":"1997","unstructured":"Huisman JA, Paulussen RJ, Geurts TB, Odink J, Rekers H. Assessment of bioequivalence after subcutaneous and intramuscular administration of urinary gonadotrophins. Hum Reprod. 1997;12:34\u20138.","journal-title":"Hum Reprod"},{"key":"451_CR31","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/jps.2600610845","volume":"61","author":"WJ Westlake","year":"1972","unstructured":"Westlake WJ. Use of confidence intervals in analysis of comparative bioavailability trials. J Pharm Sci. 1972;61:1340\u20131.","journal-title":"J Pharm Sci"},{"key":"451_CR32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2307\/2529259","volume":"32","author":"WJ Westlake","year":"1976","unstructured":"Westlake WJ. Symmetrical confidence intervals for bioequivalence trials. Biometrics. 1976;32:741\u20134.","journal-title":"Biometrics"},{"key":"451_CR33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF01068419","volume":"15","author":"DJ Schuirmann","year":"1987","unstructured":"Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987;15:657\u201380.","journal-title":"J Pharmacokinet Biopharm"},{"key":"451_CR34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/009286159002400206","volume":"24","author":"DJ Schuirmann","year":"1990","unstructured":"Schuirmann DJ. Design of bioavailability\/bioequivalence studies. Drug Inf J. 1990;24:315\u201323.","journal-title":"Drug Inf J"},{"key":"451_CR35","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/humrep\/12.11.2379","volume":"12","author":"IJM Duijkers","year":"1997","unstructured":"Duijkers IJM, Klipping C, Mulders TMT, Out HJ, Ceolingh Bennink HJT, Vemer HM. Pharmacodynamics and pharmacokinetics after repeated subcutaneous administration of three gonadotrophin preparations. Hum Reprod. 1997;12:2379\u201384.","journal-title":"Hum Reprod"},{"key":"451_CR36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0010-7824(76)90085-8","volume":"14","author":"JSE Dericks-Tan","year":"1976","unstructured":"Dericks-Tan JSE, Kr\u00f6g W, Aktories K, Taubert HD. Dose-dependent inhibition by oral contraceptives of the pituitary to release LH and FSH in response to stimulation with LHRH. Contraception. 1976;14:171\u201381.","journal-title":"Contraception"},{"issue":"2","key":"451_CR37","first-page":"420","volume":"77","author":"DJ Hemrika","year":"1993","unstructured":"Hemrika DJ, Slaats EH, Kennedy JC, de Vries Robles-Korsen TJ, Schoemaker J. Pulsatile luteinizing hormone patterns in long term oral contraceptive users. J Clin Endocrinol Metab. 1993;77(2):420\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"451_CR38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0010-7824(88)90044-3","volume":"38","author":"C Jung-Hoffmann","year":"1988","unstructured":"Jung-Hoffmann C, Heidt F, Kuhl H. Effect of two oral contraceptives containing 30 \u00b5g ethinylestradiol and 75 \u00b5g gestodene or 150 \u00b5g desogestrel upon various hormonal parameters. Contraception. 1988;38(6):593\u2013603.","journal-title":"Contraception"},{"issue":"2","key":"451_CR39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0010-7824(82)90081-6","volume":"26","author":"ID Nuttall","year":"1982","unstructured":"Nuttall ID, Elstein M, McCafferty E, Seth J, Cameron ED. The effect of ethinylestradiol 20 \u00b5g and levonorgestrel 250 \u00b5g on the pituitary-ovarian function during normal tablet-taking and when tablets are missed. Contraception. 1982;26(2):121\u201335.","journal-title":"Contraception"},{"key":"451_CR40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0010-7824(92)90151-I","volume":"46","author":"K Fotherby","year":"1992","unstructured":"Fotherby K. Clinical experience and pharmacological effects of an oral contraceptive containing 20 \u00b5g oestrogen. Contraception. 1992;46:477\u201388.","journal-title":"Contraception"},{"issue":"3","key":"451_CR41","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2125.2009.03585.x","volume":"69","author":"S Dissanayake","year":"2010","unstructured":"Dissanayake S. Assessing the bioequivalence of analogues of endogenous substances (\u2018endogenous drugs\u2019): considerations to optimize study design. Br J Clin Pharmacol. 2010;69(3):238\u201344.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"451_CR42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0015-0282(97)00503-7","volume":"69","author":"JY Cotonnec le","year":"1998","unstructured":"le Cotonnec JY, Loumaye E, Porchet HC, Beltrami V, Munafo A. Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone. Fertil Steril. 1998;69(2):201\u20139.","journal-title":"Fertil Steril"},{"issue":"4","key":"451_CR43","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0015-0282(16)56644-8","volume":"61","author":"JY Cotonnec le","year":"1994","unstructured":"le Cotonnec JY, Porchet HC, Beltrami V, Khan A, Toon S, Rowland M. Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH. Fertil Steril. 1994;61(4):669\u201378.","journal-title":"Fertil Steril"},{"key":"451_CR44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/ajcn\/28.4.333","volume":"28","author":"JA Owen","year":"1975","unstructured":"Owen JA. Physiology of the menstrual cycle. Am J Clin Nutr. 1975;28:333\u20138.","journal-title":"Am J Clin Nutr"},{"key":"451_CR45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1210\/jcem-37-1-6","volume":"37","author":"F Naftolin","year":"1973","unstructured":"Naftolin F, Yen SSC, Perlman D, Tasi CC, Parker DC, Vargo T. Nocturnal patterns of serum gonadotropins during the menstrual cycle. J Clin Endocrinol Metab. 1973;37:6\u201310.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"451_CR46","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1210\/jc.2010-2739","volume":"96","author":"KM Klingman","year":"2011","unstructured":"Klingman KM, Marsh EE, Klerman EB, Anderson EJ, Hall JE. Absence of circadian rhythms of gonadotropin secretion in women. J Clin Endocrinol Metab. 2011;96(5):1456\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"451_CR47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0748730405283244","volume":"21","author":"HB Lavoie","year":"2006","unstructured":"Lavoie HB, Marsh EE, Hall JE. Absence of apparent circadian rhythms of gonadotropins and free \u03b1-subunit in postmenopausal women: evidence for distinct regulation relative to other hormonal rhythms. J Biol Rhythms. 2006;21:58\u201367.","journal-title":"J Biol Rhythms"},{"issue":"2","key":"451_CR48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/humupd\/2.2.153","volume":"2","author":"BMJL Mannaerts","year":"1996","unstructured":"Mannaerts BMJL, Rombout F, Out HJ, Coelingh Bennink H. Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy. Hum Reprod Update. 1996;2(2):153\u201361.","journal-title":"Hum Reprod Update"},{"key":"451_CR49","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0015-0282(00)00542-2","volume":"73","author":"G Voortman","year":"2000","unstructured":"Voortman G, Mannaerts BM, Huisman JA. A dose proportionality study of subcutaneously and intramuscularly administered recombinant human follicle-stimulating hormone (Follistim*\/Puregon) in healthy female volunteers. Fertil Steril. 2000;73:1187\u201393.","journal-title":"Fertil Steril"},{"issue":"2","key":"451_CR50","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0015-0282(16)58108-4","volume":"65","author":"B Mannaerts","year":"1996","unstructured":"Mannaerts B, Fauser B, Lahlou N, Harlin J, Shoham Shoham Z, Bennink HC, et al. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism. Fertil Steril. 1996;65(2):406\u201310.","journal-title":"Fertil Steril"},{"issue":"7","key":"451_CR51","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/oxfordjournals.humrep.a138685","volume":"9","author":"DC Schoot","year":"1994","unstructured":"Schoot DC, Harlin J, Shoham Z, Mannaerts BM, Lahlou N, Bouchard P, et al. Recombinant human follicle-stimulating hormone and ovarian response in gonadotropin deficient women. Hum Reprod. 1994;9(7):1237\u201342.","journal-title":"Hum Reprod"},{"key":"451_CR52","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/jcem-68-3-693","volume":"68","author":"J Rabinovici","year":"1989","unstructured":"Rabinovici J, Blankstein J, Goldman B, Rudak E, Dor Y, Pariente C, et al. In vitro fertilization and primary embryonic cleavage are possible in 17\u03b1-hydroxylase deficiency despite extremely low intrafollicular 17-estradiol. J Clin Endocrinol Metab. 1989;68:693\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"451_CR53","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/oxfordjournals.humrep.a138634","volume":"9","author":"P Devroey","year":"1994","unstructured":"Devroey P, Mannaerts B, Smitz J, Coelingh Bennink H, Van Steirteghem A. Clinical outcome of a pilot efficacy study on recombinant human FSH (Org 32489) combined with various GnRH agonist regimens. Hum Reprod. 1994;9:1064\u20139.","journal-title":"Hum Reprod"},{"issue":"7","key":"451_CR54","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/09513590.2013.788641","volume":"29","author":"C Alviggi","year":"2013","unstructured":"Alviggi C, Cognigni GE, Morgante G, Cometti B, Ranieri A, Strina I, et al. A prospective, randomised, investigator-blind, controlled, clinical study on the clinical efficacy and tolerability of two highly purified hMG preparations administered subcutaneously in women undergoing IVF. Gynecol Endocrinol. 2013;29(7):695\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"451_CR55","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.fertnstert.2008.01.064","volume":"91","author":"VL Baker","year":"2009","unstructured":"Baker VL, Fujimoto VY, Kettel LM, Adamson GD, Hoehler F, Jones CE, et al. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial. Fertil Steril. 2009;91(4):1005\u201311.","journal-title":"Fertil Steril"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0451-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-016-0451-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0451-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T10:56:20Z","timestamp":1568372180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-016-0451-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1007\/s40261-016-0451-6","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]}}}